Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma
2023 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-023-28688-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
80
Citations
5
h-index
3
i10-index
Koki Hashimoto is an academic researcher from Japanese Foundation For Cancer Research. The author has contributed to research in topics: Renal cell carcinoma treatment & Nausea and vomiting management & Cancer Immunotherapy and Biomarkers. The author has an h-index of 5, co-authored 10 publications.
ORCID: 0000-0001-6637-4433https://doi.org/10.1038/s41598-023-28688-9
https://doi.org/10.1186/s40780-025-00490-x
Click to start Chat